The Mizuho Lowers Envision Healthcare Co. (EVHC) Price Target to $60.00

The Mizuho Lowers Envision Healthcare Co. (EVHC) Price Target to $60.00

Several other brokerages have also commented on EVHC. Royal Bank of Canada reaffirmed an outperform rating and issued a $80.00 price target (down previously from $87.00) on shares of Envision Healthcare in a research note on Wednesday, March 1st. Jefferies Group LLC reaffirmed a buy rating and issued a $82.00 price target (down previously from $90.00) on shares of Envision Healthcare in a research note on Wednesday, March 1st. Zacks Investment Research raised Envision Healthcare from a hold rating to a buy rating and set a $76.00 price target on the stock in a research note on Wednesday, February 1st. TheStreet lowered Envision Healthcare from a b- rating to a c+ rating in a research note on Thursday, March 9th. Finally, Cantor Fitzgerald reaffirmed an overweight rating on shares of Envision Healthcare in a research note on Thursday, March 16th. One analyst has rated the stock with a sell rating, two have given a hold rating, ten have issued a buy rating and one has given a strong buy rating to the stock. The stock currently has an average rating of Buy and a consensus target price of $72.00.

Envision Healthcare Co. (NYSE:EVHC) had its price target decreased by Mizuho from $70.00 to $60.00 in a research report report published on Tuesday. Mizuho currently has a neutral rating on the stock.

Shares of Envision Healthcare (NYSE EVHC) opened at 55.73 on Tuesday. The company’s market capitalization is $6.47 billion. Envision Healthcare has a 1-year low of $53.12 and a 1-year high of $85.24. The firm has a 50-day moving average price of $56.27 and a 200-day moving average price of $63.92. Envision Healthcare (NYSE:EVHC) last released its quarterly earnings data on Tuesday, May 2nd. The company reported $0.69 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.69. The business had revenue of $1.88 billion for the quarter, compared to analysts’ expectations of $2.52 billion. Envision Healthcare had a return on equity of 8.05% and a net margin of 6.06%. Equities analysts anticipate that Envision Healthcare will post $1.40 earnings per share for the current year.

Shares of Envision Healthcare (NYSE EVHC) opened at 55.73 on Tuesday. The company’s market capitalization is $6.47 billion. Envision Healthcare has a 1-year low of $53.12 and a 1-year high of $85.24. The firm has a 50-day moving average price of $56.27 and a 200-day moving average price of $63.92. In other news, Director John Thomas Gawaluck purchased 1,500 shares of the business’s stock in a transaction dated Friday, March 10th. The shares were acquired at an average price of $66.65 per share, with a total value of $99,975.00. Following the completion of the purchase, the director now directly owns 6,080 shares of the company’s stock, valued at approximately $405,232. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Corporate insiders own 2.30% of the company’s stock.

Institutional investors have recently modified their holdings of the stock. Livforsakringsbolaget Skandia Omsesidigt purchased a new position in shares of Envision Healthcare during the first quarter valued at about $135,000. Korea Investment CORP purchased a new position in shares of Envision Healthcare during the first quarter valued at about $141,000. Pacer Advisors Inc. raised its position in shares of Envision Healthcare by 7.4% in the third quarter. Pacer Advisors Inc. now owns 7,045 shares of the company’s stock valued at $157,000 after buying an additional 484 shares during the period. Ameritas Investment Partners Inc. purchased a new position in shares of Envision Healthcare during the first quarter valued at about $172,000. Finally, First Interstate Bank purchased a new position in shares of Envision Healthcare during the first quarter valued at about $184,000. 35.96% of the stock is currently owned by institutional investors and hedge funds. About Envision Healthcare

Envision Healthcare Holdings, Inc, formerly CDRT Holding Corporation, is a holding company. The Company, through its subsidiary, provides physician-led medical services in the United States. It operates in two segments: EmCare Holdings, Inc (EmCare) and American Medical Response, Inc (AMR). Its EmCare segment is a provider of integrated facility-based and post-acute care physician services to healthcare facilities in the United States.new TradingView.widget({ “height”: 400, “width”: 625, “symbol”: “EVHC”, “interval”: “D”, “timezone”: “Etc/UTC”, “theme”: “White”, “style”: “1”, “locale”: “en”, “toolbar_bg”: “#f1f3f6”, “enable_publishing”: false, “hideideas”: true, “referral_id”: “2588”});

Related posts

Leave a Comment